BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14971804)

  • 1. Lack of appropriate formulations of medicines for children in the community.
    Schirm E; Tobi H; de Vries TW; Choonara I; De Jong-van den Berg LT
    Acta Paediatr; 2003 Dec; 92(12):1486-9. PubMed ID: 14971804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for unlicensed and off-label drug use in children outside the hospital.
    Schirm E; Tobi H; de Jong-van den Berg LT
    Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlicensed and off-label prescription of respiratory drugs to children.
    't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Strickerf BH
    Eur Respir J; 2004 Feb; 23(2):310-3. PubMed ID: 14979509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric formulations--getting to the heart of the problem.
    Standing JF; Tuleu C
    Int J Pharm; 2005 Aug; 300(1-2):56-66. PubMed ID: 15979830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.
    't Jong GW; Vulto AG; de Hoog M; Schimmel KJ; Tibboel D; van den Anker JN
    Pediatrics; 2001 Nov; 108(5):1089-93. PubMed ID: 11694685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of unlicensed and off-label drugs in hospitalized children].
    Lifshitz M; Gavrilov V; Gorodischer R
    Harefuah; 1999 Dec; 137(11):532-4, 591. PubMed ID: 10959365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlicensed and off label prescribing of drugs in general practice.
    McIntyre J; Conroy S; Avery A; Corns H; Choonara I
    Arch Dis Child; 2000 Dec; 83(6):498-501. PubMed ID: 11087285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of Oral Formulations Labeled for Use in Young Children in Serbia, Germany and the USA.
    Bajcetic M; Kearns GL; Jovanovic I; Brajovic M; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5668-73. PubMed ID: 26323413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlicensed and off-label uses of medicines: definitions and clarification of terminology.
    Aronson JK; Ferner RE
    Br J Clin Pharmacol; 2017 Dec; 83(12):2615-2625. PubMed ID: 28779556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label and unlicensed medicines to hospitalised children in Norway.
    Teigen A; Wang S; Truong BT; Bjerknes K
    J Pharm Pharmacol; 2017 Apr; 69(4):432-438. PubMed ID: 27334565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The incidence of prescriptions without marketing product license in a neonatal intensive care unit].
    Avenel S; Bomkratz A; Dassieu G; Janaud JC; Danan C
    Arch Pediatr; 2000 Feb; 7(2):143-7. PubMed ID: 10701058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
    Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
    Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects.
    van Riet-Nales DA; Schobben AF; Vromans H; Egberts TC; Rademaker CM
    Arch Dis Child; 2016 Jul; 101(7):662-9. PubMed ID: 26979250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.